SYNTA PHARMACEUTICALS CORP - COM (SNTA)

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
73,457,827
Share change
+18,324,258
Total reported value
$142,526,963
Put/Call ratio
234%
Price per share
$1.94
Number of holders
88
Value change
+$35,315,478
Number of buys
52
Number of sells
30

Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q1 2015

As of 31 Mar 2015, SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,457,827 shares. The largest 10 holders included CAXTON CORP, JENNISON ASSOCIATES LLC, FMR LLC, BlackRock Fund Advisors, ARMISTICE CAPITAL, LLC, Jefferies Group LLC, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 88 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.